Search results
What Is Friedreich's Ataxia?
Verywell Health via Yahoo News· 1 year agoFriedreich's ataxia is a rare disease that affects your central nervous system. Individuals with late-onset Friedreich's ataxia (LOFA) and very...
Reata Nears Breakout After Snagging FDA Blessing To Launch Its Friedreich's Ataxia Drug
Investor's Business Daily· 11 months agoReata Pharmaceuticals won the Food and Drug Administration's blessing to go ahead with production of...
Why Reata Pharma Shares Are Skyrocketing Today
Benzinga via Yahoo Finance· 1 year agoThe FDA approved Reata Pharmaceuticals Inc's (NASDAQ: RETA) Skyclarys (omaveloxolone) for Friedreich's ataxia in adults and adolescents aged 16 and...
Reata (RETA) Friedreich's Ataxia NDA Gets Priority Review
Zacks via Yahoo Finance· 2 years agoReata (RETA) is seeking approval for omaveloxolone as a treatment for neuromuscular disorder...
Reata Surges 12% Over Three Days; CEO Reflects On The Tricky Path To Launch A First-Ever Drug
Investor's Business Daily· 11 months agoReata Pharmaceuticals Chief Executive Warren Huff says Friedreich's ataxia is "the worst disease."...
Reata (RETA) Stock Jumps as FDA Approves Rare Disease Drug
Zacks via Yahoo Finance· 1 year agoSkyclarys is the first drug to be approved specifically for the treatment of Friedreich's ataxia and...
Reata (RETA) Stock Doubles This Year on Skyclarys FDA Nod
Zacks via Yahoo Finance· 1 year agoReata Pharmaceuticals’ RETA shares have more than doubled in 2023. The main reason for the surge is...
Ukrainian journalists, including Sevhil Musaieva, honoured with the Hanns Joachim Friedrichs Award
Ukrayinska Pravda via Yahoo News· 8 months agoThree Ukrainian journalists have received a special German Hanns Joachim Friedrichs award. Source:...
PTC Therapeutics' Barrage Of Bad News Is Good News For Rival Reata Pharmaceuticals — Here's Why
Investor's Business Daily· 12 months agoPTC stock plummeted Wednesday and gave its closest rival a boost after the company's treatment for a...
Biogen Skids On 'Low-Quality' Beat, Cuts Profit Guidance Following Reata Buyout
Investor's Business Daily· 6 months agoBiogen stock skidded Wednesday on a "low-quality" sales beat that relied on other revenue. But...